Thomas Insel, MD Named New Director of NIMH

NAMI E-News September 11, 2002 Vol. 02-95
____________________________________

Thomas Insel, MD Named New Director of NIMH

The National Institutes of Health yesterday announced that Thomas Insel, MD of Emory University in Atlanta has been named as the new Director of the National Institute of Mental Health (NIMH). Dr. Insel, is currently Professor, Department of Psychiatry and Director of the Center for Behavioral Neuroscience at Emory. He is expected to begin his appointment at NIMH in mid-November. Below is a statement issued by NAMI President Jim McNulty on the appointment of Dr. Insel (including additional details on his background and experience). Jim McNulty serves on the NIMH Advisory Council and was a member of the Search Committee that selected the NIMH Director.

Statement of Jim McNulty,
NAMI National Board President and Member, NIMH Search Committee

The National Alliance for the Mentally Ill (NAMI) is pleased to welcome the selection of Thomas Insel, M.D. of Emory University in Atlanta as the new Director of the National Institute of Mental Health (NIMH).

Dr. Insel, is currently Professor, Department of Psychiatry and Director of the Center for Behavioral Neuroscience at Emory and is expected to begin his tenure at NIMH in November. As a member of the search committee that recommended him, I am familiar with his qualifications and excited about the renewed leadership he will bring to scientific research into the causes and treatment of severe mental illness. NAMI looks forward to working him.

Dr. Insel joined NIMH in 1979 as a clinical associate in its Clinical Neuropharmacology Branch and later held several administrative and leadership posts. Before moving to Emory University in 1994, he conducted research in obsessive-compulsive disorder (OCD), initiating some of the first treatment trials for OCD using serotonin reuptake inhibitors. In 1984, Dr. Insel launched a research program in social neuroscience, focusing on the neurobiology of complex social behaviors in animals. Using molecular, cellular, and pharmacological approaches, Dr. Insel focused on the link between neuropeptides, oxytocin and vasopressin, in behavior and aggression.

He is a graduate of Boston University's College of Liberal Arts and its Medical School. He did his internship at Berkshire Medical Center, Pittsfield, Massachusetts, and his residency at the Langley Porter Neuropsychiatric Institute at the University of California San Francisco.

As Professor of Psychiatry in Emory's School of Medicine, Dr. Insel has been Director of the Yerkes Regional Primate Research Center, where he built one of the nation's leading HIV vaccine research programs. He also has served as founding director of the Center for Behavioral Neuroscience, a science and technology center, funded by the National Science Foundation (NSF).

The Center has developed an interdisciplinary consortium for research and education at eight Atlanta colleges and universities. Dr. Insel's research includes the role of oxytocin in social attachment and behavior, and under an NIMH grant, development of an autism research center.

He has served on 10 professional editorial boards and is a fellow of the American College of Neuropsychopharmacology. He has received awards from the National Alliance for Research on Schizophrenia and Depression (NARSAD), the Society for Biological Psychiatry, and the U.S. Public Health Service (USPHS).

We look forward to supporting his vision and commitment in working together to invest in greater research to improve the lives of people challenged by mental illnesses, and to achieve greater, readier recoveries.

The NAMI E-News is an electronic newsletter delivering the latest in federal action alerts, legislative and policy updates, and NAMI press releases. Provided free of charge as a public service, the NAMI E-News is read by more than 16,500 NAMI members, policymakers, federal and state legislators, media, providers, health care policy experts, and others interested in improving the lives of individuals with severe mental illnesses and their families.

Contributions to support the NAMI E-News are welcomed and can be made online http://www.nami.org/about/development/index.html; via mail (make check payable to NAMI and send to NAMI, P.O. Box 79972, Baltimore, MD 21279-0972); or through the Combined Federal Campaign (CFC #0538).

Currently, NAMI Members number 220,000.

Thank you.

Last Updated on 02/20/2005 webmaster@namiscc.org

Opinions expressed in this web site do not necessarily reflect the views of NAMI Santa Cruz County, NAMI California or any affiliated organizations. We attempt to present a balanced perspective on issues by presenting multiple viewpoints.

FAIR USE NOTICE: This may contain copyrighted (©) material the use of which has not always been specifically authorized by the copyright owner. Such material is made available to advance understanding of ecological, political, human rights, economic, democracy, scientific, moral, ethical, and social justice issues, etc. It is believed that this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml If you wish to use copyrighted material for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.